RBC Capital Maintains Sector Perform on Bio-Techne, Lowers Price Target to $70
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Conor McNamara maintains a Sector Perform rating on Bio-Techne (NASDAQ:TECH) but lowers the price target from $72 to $70.
August 08, 2024 | 7:51 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
RBC Capital has maintained its Sector Perform rating on Bio-Techne but has lowered the price target from $72 to $70.
The lowering of the price target by RBC Capital suggests a slightly less optimistic outlook for Bio-Techne, which could lead to a short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100